— Know what they know.
Not Investment Advice

CUBT OTC

Curative Biotechnology, Inc.
1W: -16.3% 1M: +4.0% 3M: -22.6% YTD: +25.1% 1Y: -27.4% 3Y: -48.4% 5Y: -94.5%
$0.93
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $6.3M mcap · 1M float · 0.052% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$2M -16.9% ▼
5Y CAGR: +122.4%
Total Liabilities
$7M +23.2% ▲
5Y CAGR: +77.9%
Shareholders Equity
-$5M -56.3% ▼
Cash & Investments
$20K -65.4% ▼
Total Debt
$1M -39.4% ▼
5Y CAGR: +542.7%
Net Debt
$1M -38.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$161K$670K$59K$56K$20K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$161K$670K$59K$56K$20K
Net Receivables$70K$25K$0$116K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$2M$754K$69K$604K$212K
Property, Plant & Equip.$2K$7K$6K$6K$2K
Goodwill & Intangibles$140K$2M$2M$1M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$93K$390K$571K$601K
Total Non-Current Assets$143K$2M$2M$2M$2M
Total Assets$2M$2M$2M$3M$2M
— Liabilities —
Accounts Payable$98K$727K$3M$3M$4M
Short-Term Debt$560K$0$1M$2M$1M
Deferred Revenue-$98$0$0$0$0
Other Current Liabilities$7K$3K$42K$0$2M
Total Current Liabilities$665K$730K$5M$6M$7M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$6M$18M$18M$0$0
Total Non-Current Liabilities$6M$18M$18M$0$0
Total Liabilities$7M$19M$23M$6M$7M
— Equity —
Common Stock$83$57K$58K$90K$92K
Retained Earnings-$8M-$27M-$32M-$38M-$42M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$2M$2M-$3M-$3M-$5M
Total Liabilities & Equity$2M$2M$2M$3M$2M
— Key Metrics —
Total Debt$560K$0$1M$2M$1M
Net Debt$399K-$670K$1M$2M$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms